- Report
- July 2025
- 200 Pages
Mexico
From €2199EUR$2,490USD£1,908GBP
- Report
- August 2022
- 382 Pages
Global
From €3090EUR$3,500USD£2,682GBP
- Report
- October 2021
- 306 Pages
Global
From €3311EUR$3,750USD£2,873GBP
- Report
- April 2021
- 377 Pages
Global
From €3527EUR$3,995USD£3,061GBP
- Report
- March 2021
Global
From €3311EUR$3,750USD£2,873GBP
- Report
- March 2021
- 214 Pages
Global
From €1766EUR$2,000USD£1,532GBP
- Report
- November 2023
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- October 2023
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- October 2023
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- January 2024
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- September 2024
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- September 2024
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- September 2024
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- January 2024
- 150 Pages
Global
From €3399EUR$3,850USD£2,950GBP
€4282EUR$4,850USD£3,716GBP
- Report
- July 2023
- 110 Pages
Global
From €3973EUR$4,500USD£3,448GBP
- Report
- January 2023
- 117 Pages
Global
From €3973EUR$4,500USD£3,448GBP
- Report
- July 2024
- 100 Pages
Global
From €3311EUR$3,750USD£2,873GBP
- Report
- November 2023
- 30 Pages
Global
From €2870EUR$3,250USD£2,490GBP
- Report
- August 2024
- 149 Pages
Global
From €2648EUR$2,999USD£2,298GBP
- Report
- July 2022
- 40 Pages
China
From €2825EUR$3,200USD£2,452GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more